110 related articles for article (PubMed ID: 3701061)
1. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.
Taylor RP; Kujala G; Edberg JC; Foreman P; Davis JS; Wright E
J Immunol; 1986 May; 136(10):3785-92. PubMed ID: 3701061
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
Taylor RP; Kujala G; Wilson K; Wright E; Harbin A
J Immunol; 1985 Apr; 134(4):2550-8. PubMed ID: 3919101
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
4. Clearance kinetics and immunochemistry in rabbits of soluble antibody/DNA immune complexes. Effects of antibody class and DNA conformation.
Edberg JC; Kujala GA; Taylor RP
J Immunol; 1987 Jul; 139(1):180-7. PubMed ID: 3584985
[TBL] [Abstract][Full Text] [Related]
5. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
6. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation.
Edberg JC; Kujala GA; Taylor RP
J Immunol; 1987 Aug; 139(4):1240-4. PubMed ID: 3611789
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
Taylor RP; Wright EL; Pocanic F
J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
[TBL] [Abstract][Full Text] [Related]
8. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
9. In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits.
Brown DL; Harkiss GD
Clin Exp Immunol; 1981 Feb; 43(2):231-9. PubMed ID: 6974064
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
11. Clearance and organ localization of small DNA anti-DNA immune complexes in mice.
Emlen W; Burdick G
J Immunol; 1988 Mar; 140(6):1816-22. PubMed ID: 3257987
[TBL] [Abstract][Full Text] [Related]
12. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
14. Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor.
Tesar JT; Schmid FR
J Immunol; 1970 Nov; 105(5):1206-14. PubMed ID: 5312663
[No Abstract] [Full Text] [Related]
15. [Cryoglobulinemia type II].
Madi N; Schifferli JA
Nephrologie; 1990; 11(4):237-41. PubMed ID: 2074925
[TBL] [Abstract][Full Text] [Related]
16. Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.
Hogben DN; Devey ME
Clin Exp Immunol; 1986 Dec; 66(3):648-53. PubMed ID: 3568452
[TBL] [Abstract][Full Text] [Related]
17. Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.
Riley RL; Addis DJ; Taylor RP
J Immunol; 1980 Jan; 124(1):1-7. PubMed ID: 6985634
[TBL] [Abstract][Full Text] [Related]
18. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
19. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.
Skogh T; Stendahl O
Immunology; 1983 May; 49(1):53-9. PubMed ID: 6404812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
